Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines

Genes and Development

Volumn 18, Issue 23, 2004, Pages 2867-2872

  Yu, Yunkai ^a   Xiao, Zuoxiang ^b   Ehrlich, Elana S ^a   Yu, Xianghui ^c   Yu, Xiao Fang ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

APOBEC3G; Cul5; E3 ubiquitin ligase; ElonginC; HIV 1 Vif; SOCS box

Indexed keywords

CYSTEINE; SUPPRESSOR OF CYTOKINE SIGNALING; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; UBIQUITINATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; CULLIN PROTEINS; CYSTEINE; DNA PRIMERS; GENE PRODUCTS, VIF; HIV-1; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; PLASMIDS; REPRESSOR PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 10044228286     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1250204     Document Type: Article

References (33)

1. Aso, T., Haque, D., Barstead, R.J., Conaway, R.C., and Conaway, J.W. 1996. The inducible elongin A elongation activation domain: Structure, function and interaction with the elongin BC complex. EMBO J. 15: 5557-5566.
2. Chackerian, B., Long, E.M., Luciw, P.A., and Overbaugh, J. 1997. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71: 3932-3939.
3. Conticello, S.G., Harris, R.S., and Neuberger, M.S. 2003. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13: 2009-2013.
4. Deshaies, R.J. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15: 435-467.
5. Dettenhofer, M., Cen, S., Carlson, B.A., Kleiman, L., and Yu, X.F. 2000. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription. J. Virol. 74: 8938-8945.
6. Harris, R.S., Bishop, K.N., Sheehy, A.M., Craig, H.M., Petersen-Mahrt, S.K., Watt, I.N., Neuberger, M.S., and Malim, M.H. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
7. Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin Jr., W.G., Conaway, R.C., and Conaway, J.W. 1998. The Elongin BC complex interacts with the conserved SOCS box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes & Dev. 12: 3872-3881.
8. Kao, S., Khan, M.A., Miyagi, E., Plishka, R., Buckler-White, A., and Strebel, K. 2003. The human immunodeficiency virus Type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. J. Virol. 77: 11398-11407.
9. Kile, B.T., Schulman, B.A., Alexander, W.S., Nicola, N.A., Martin, H.M., and Hilton, D.J. 2002. The SOCS-box: A tale of destruction and degradation. Trends Biochem. Sci. 27: 235-241.
10. Lecossier, D., Bouchonnet, F., Clavel, F., and Hance, A.J. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300: 1112.
11. Liu, B., Yu, X., Luo, K., Yu, Y., and Yu, X.F. 2004. Influence of primate lentiviral Vif and proteasome inhibitors on HIV-1 virion packaging of APOBEC3G. J. Virol 78: 2072-2081.
12. Lonergan, K.M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R.C., Conaway, J.W., and Kaelin Jr., W.G. 1998. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18: 732-741.
13. Ma, X.Y., Sova, P., Chao, W., and Volsky, D.J. 1994. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J. Virol. 68: 1714-1720.
14. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., and Trono, D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
15. Margottin, F., Bour, S.P., Durand, H., Selig, L., Benichou, S., Richard, V., Thomas, D., Strebel, K., and Benarous, R. 1998. A novel human WD protein, h-β TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1: 565-574.
16. Mariani, R., Chen, D., Schrofelbauer, B., Navarro, F., Konig, R., Bollman, B., Munk, C., Nymark-McMahon, H., and Landau, N.R. 2003. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31.
17. Marin, M., Rose, K.M., Kozak, S.L., and Kabat, D. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9: 1398-1403.
18. Mehle, A., Strack, B., Ancuta, P., Zhang, C., McPike, M., and Gabuzda, D. 2003. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J. Biol. Chem. 279: 7792-7798.
19. Pintard, L., Willems, A., and Peter, M. 2004. Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J. 23: 1681-1687.
20. Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
21. Sheehy, A.M., Gaddis, N.C., and Malim, M.H. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 9: 1404-1407.
22. Shindo, K., Takaori-Kondo, A., Kobayashi, M., Abudu, A., Fukunaga, K., and Uchiyama, T. 2003. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem. 278: 44412-44416.
23. Simon, J.H., Sheehy, A.M., Carpenter, E.A., Fouchier, R.A., and Malim, M.H. 1999. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J. Virol. 73: 2675-2681.
24. Sova, P., Chao, W., and Volsky, D.J. 1997. The redox state of cysteines in human immunodeficiency virus type 1 Vif in infected cells and in virions. Biochem. Biophys. Res. Commun. 240: 257-260.
25. Stebbins, C.E., Kaelin Jr., W.G., and Pavletich, N.P. 1999. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function. Science 284: 455-461.
26. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W.C. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12: 591-601.
27. Suspene, R., Sommer, P., Henry, M., Ferris, S., Guetard, D., Pochet, S., Chester, A., Navaratnam, N., Wain-Hobson, S., and Vartanian, J.P. 2004. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 32: 2421-2429.
28. Xu, H., Svarovskaia, E.S., Barr, R., Zhang, Y., Khan, M.A., Strebel, K., and Pathak, V.K. 2004. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Proc. Natl. Acad. Sci. 101: 5652-5657.
29. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X.F. 2003. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056-1060.
30. Yu, Q., Konig, R., Pillai, S., Chiles, K., Kearney, M., Palmer, S., Richman, D., Coffin, J.M., and Landau, N.R. 2004. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nat. Struct. Mol. Biol. 11: 435-442.
31. Zhang, J.G., Farley, A., Nicholson, S.E., Willson, T.A., Zugaro, L.M., Simpson, R.J., Moritz, R.L., Cary, D., Richardson, R., Hausmann, G., et al. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. 96: 2071-2076.
32. Zhang, H., Yang, B., Pomerantz, R.J., Zhang, C., Arunachalam, S.C., and Gao, L. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98.
33. Zheng, N., Schulman, B.A., Song, L., Miller, J.J., Jeffrey, P.D., Wang, P., Chu, C., Koepp, D.M., Elledge, S.J., Pagano, M., et al. 2002. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416: 703-709.